Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique

Abstract

Aim:

To report the outcome of a series of patients with chronic venous disease due to incompetence of the great saphenous vein (GSV) managed by ultrasound-guided foam sclerotherapy (USGFS).

Design:

Controlled clinical trial with maximum 5-year follow-up of results of USGFS of the GSV with new parameters of the procedure.

Materials and Methods:

This research analyzes the results of USGFS of the GSV (395 GSV) and its tributaries in 326 patients with varicose veins of the lower extremities over the period from January 2009 to January 2014 with the following parameters of the procedure: 60° limb elevation, calf bandage, and cooled foam injection.

Results:

Ultrasound control of 395 GSV after the first injection of sclerosant from the sixth to the eighth day revealed GSV occlusion in the femoral segment with the absence of reflux in 94.9% of cases (375 GSV). After 5-year follow-up, GSV occlusion was diagnosed in 91.9% of cases.

Conclusion:

Our improved technique of foam sclerotherapy allows improving immediate and long-term results. This technique is characterized by the low incidence of side effects and complications.

Keywords

varicose veins USGFS the great saphenous vein

Get full access to this article

View all access options for this article.

References

Nicolaides

Kakkos

Eklof

. Management of chronic venous disorders of the lower limbs—guidelines according to scientific evidence. Int Angiol. 2014;33(2):87–208.

Hill

Hamilton

Fung

. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg. 2008;48(4):934–939.

Rabe

Breu

Cavezzi

. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29(6):338–354.

Bergan

Bunke-Paquette

. The Vein Book. 2nd ed. New York: Oxford University Press; 2014.

Valenzuela

Wong

Connor

. Foam sclerosants are more stable at lower temperatures. Eur J Vasc Endovasc Surg. 2013;46(5):593–599.

Armitage

. Test for linear trend in proportions and frequencies. Biometrics. 1955;11(3):375–386.

R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. http://www.R-project.org/. Accessed February 17, 2016. Updated October 31, 2016.

Rabe

Otto

Schliephake

Pannier

. Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg. 2008;35(2):238–245.

Cabrera

Jr Garcia-Olmedo

. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long term outcomes. Phlebology. 2000;15(1):19–23.

10.

Myers

Jolley

Clough

Kirwan

. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg. 2007;33(1):116–121.

11.

Frullini

Cavezzi

. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg. 2002;28(1):11–15.

12.

Smith

. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006;32(5):577–583.

13.

Darvall

Bate

Adam

Silverman

Bradbury

. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic primary great saphenous varicose veins. Eur J Vasc Endovasc Surg. 2010;40(4):534–539.

14.

Stucker

Kobus

Altmeyer

Reich-Schupke

. Review of published information on foam sclerotherapy. Dermatol Surg. 2010;36(suppl 2):983–992.

15.

Redondo

Cabrera

. Microfoam sclerotherapy. Semin Cutan Med Surg. 2005;24(4):175–183.

16.

Pascarella

Bergan

Mekenas

. Severe chronic venous insufficiency treated by foamed sclerosant. Ann Vasc Surg. 2006;20(1):83–91.

17.

Rasmussen

Lawaetz

Bjoern

Vennits

Blemings

Eklof

. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98(8):1079–1087.

18.

Gonzalez-Zeh

Armisen

Barahon

. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results. J Vasc Surg. 2008;48(4):940–946.

19.

Smith

Goldman

. Tumescent anesthesia in ambulatory phlebectomy. Dermatol Surg. 1998;24(4):453–456.

20.

Thibault

. Internal compression (peri-venous compression) following ultrasound guided sclerotherapy to the great and small saphenous veins. ANZ J Phlebol. 2005;9(1):29.

21.

Cavezzi

Mosti

Di Paolo

Tessari

Campana

Urso

. Catheter-directed foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg. 2014;48(5):597.

22.

Devereux

Recke

Westermann

Recke

Kahle